3DCRT | 3 Dimensional Conformal Radiotherapy
|
5-FU | 5-Fluorouracil (anti cancer drug)
|
6-MP | 6-Mercaptopurine (anti cancer drug)
|
6-TG | 6-Thioguanine (anti cancer drug)
|
AA | Anaplastic Anaemia
|
AACR | American Association for Cancer Research
|
ABC | Advanced Breast Cancer
|
ABMT | Autologous bone marrow transplant
|
ABPI | Association of the British Pharmaceutical Industry
|
ABTA | American Brain Tumour Association
|
ACDM | Association for Clinical Data Management
|
ACRPI | Association of Clinical Research for the Pharmaceutical Industry
|
ACS | American Cancer Society
|
ADR | Adverse Drug Reaction
|
AE | Adverse event
|
AFP | Alphafetoprotein - eg. expressed by germ cell tumours and other cancers
|
AIDS | Acquired immune deficiency syndrome
|
AIOM | Italian Association for Medical Oncology
|
AIRO | Associazione Italiana di Radioterapia Oncologica
|
AJCC | American Joint Committee on Cancer
|
ALAT | Alanine aminotransferase / alinine transaminase
|
ALCL | Anaplastic Large-cell Lymphoma
|
ALL | Acute lymphoblastic leukaemia
|
ALT | Alanine Aminotransferase
|
AMKL | acute megakaryocytic leukemia
|
AML | Acute Myeloid leukaemia
|
ANC | Absolute neutrophil count
|
ANED | Alive no evidence of disease
|
ANLL | Acute non-lymphatic leukaemia
|
ARMS | Alveolar rhabdomyosarcoma
|
ASCO | American Society of Clinical Oncology
|
ASH | American Society for Hematology
|
ASR | Age Standardised Rate (Incidence)
|
ASTRO | American Society for Therapeutic Radiology and Oncology
|
AUC | Area under the curve
|
B-ALL | B-cell Acute Lymphoblastic Leukaemia
|
BACR | British Association for Cancer Research
|
BAER | Brainstem Auditory Evoked Responce
|
BASO | British Association of Surgical Oncologists
|
BCC | Basal Cell Carcinoma
|
BID / BD | Twice a day (bis in die)
|
BM | Bone Marrow
|
BM | Blood Monitoring (eg for glucose)
|
BMA | British Medical Association
|
BMJ | British Medical Journal
|
BMR | Basal Metabolic Rate
|
BMT | Bone Marrow Transplant
|
BNF | British National Formulary
|
BNLI | British National Lymphoma Investigation
|
BOA | British Oncology Association
|
BODMA | British Oncology Data Managers Association (UK)
|
BP | Blood pressure
|
BRM | Biological Response Modifier
|
BSA | Body Surface Area
|
BSE | Breast Self Examination
|
Bx | Biopsy
|
C/O | Complaining of
|
C/W | Continue With
|
C1 - C7 | Cervical vertebrae (spine eg. C7 = seventh cervical vertebra)
|
Ca | Cancer; carcinoma
|
Ca | Calcium
|
CALGB | Cancer and Leukemia Group B (USA)
|
cALL | Common ALL
|
CAT | Computerised axial tomography (scan)
|
cc | Cubic centimeter
|
CCF | Congestive Cardiac Failure
|
CCG | Children's Cancer Group (USA)
|
CCR | Continuous complete remission
|
CCRG | Children's Cancer Research Group (Oxford, UK)
|
CCS | Canadian Cancer Society
|
CEA | Carcinoembryonic Antigen (tumour marker)
|
CGH | Comparative Genomic Hybridisation - cytogenetics method
|
CGL | Chronic Granulocytic Leukaemia
|
cGy | Centi Gray (unit of radiation)
|
CHF | Congestive heart failure
|
CLL | Chronic lymphocytic Leukaemia
|
cm | centimeter - 0.01 meters
|
CML | Chronic myeloid leukaemia
|
CMML | chronic myelomonocytic leukemia
|
CMV | Cytomegalo virus
|
CNS | Central nervous system - the brain and spine
|
COS | Canadian Oncology Society
|
CPM | Cyclophosphamide (anti cancer drug)
|
CPR | Cardio pulmonary resuscitation
|
CR | Complete remission / complete response
|
CRA | Clinical Research Associate
|
CRC | Cancer Research Campaign (UK)
|
CRC | Colorectal carcinoma
|
CRF | Case Report Forms
|
CRF | Chronic renal failure
|
CRO | Contract Research Organisation
|
CSF | Cerebro spinal fluid
|
CSF | Colony-stimulating Factor
|
CSM | Committee on Safety of Medicines (UK)
|
CT | Computerised axial tumography (scan)
|
CT | Chemotherapy
|
CTC | Common Toxicity Criteria
|
CTCL | Cutaneous T-Cell Lymphoma
|
CTO | Clinical Trials Office
|
CTX | Clinical Trials Exemption
|
CVA | Cardiovascular Accident (stroke)
|
CVC | Central venous catheters
|
CVP | Central Venous Pressure
|
CXR | Chest X-Ray
|
D/C | Discharge
|
D/H | Drug History
|
D/W | Discussed With
|
DCIS | Ductal Carcinoma In Situ - type of breast cancer
|
DDAVP | Desmopressin test for urine osmolality
|
DDx | Differential diagnosis
|
DFI | Disease Free Interval
|
DFS | Disease Free Survival - time without disease prior to relapse or last follow-up
|
DI | Diabetes Incipidus
|
dl | deciletre - 0.01 litres
|
DLBCL | Diffuse Large B-cell Lymphoma
|
DLCL | Diffuse large-cell lymphoma
|
DLS | Date last seen
|
DLT | Dose limiting toxicity - determined by phase 1 studies
|
DMC | Data Monitoring Commitee
|
DNA | Deoxyribonucleic acid
|
DNA | Did Not Attend (clinic)
|
DNR | Do Not Resusitate
|
DOA | Dead on Arival
|
Dx | Diagnosis
|
EACR | European Association for Cancer Research
|
EANO | European Association for NeuroOncology
|
EBM | Evidence-Based Medicine
|
EBMT | European Group for Blood and Marrow Transplantation
|
EBV | Epstein-Barr Virus
|
ECG | Electrocardiogram - heart scan
|
ECOG | Eastern Cooperative Group (USA)
|
EDTA | ethylendiaminetetraacetic acid - used in measuring kidney function
|
EEG | Electroencephalogram - brain scan
|
EFS | Event Free Survival - time from diagnosis to defined events (eg relapse or deat
|
EICESS | European Intergroup Ewing's Sarcoma Study
|
EJC | European Journal of Cancer
|
EMUO | Early Morning Urine Osmolality (evaluating urine concentration)
|
ENSG | European Neuroblastoma Study Group
|
ENT | Ear nose throat
|
EOI | European Osteosarcoma Intergroup
|
EORTC | European Organisation for Research and Treatment of Cancer
|
ESO | European School of Oncology
|
ESR | Erythrocyte Sedimentation rate
|
ESTRO | European Society for Therapeutic Radiation and Oncology
|
ETS | Environmental Tobacco Smoke
|
F/H | Family history
|
FAB | French American and British classification scheme for leukaemia
|
FBC | Full Blood Count
|
FDA | Food and Drug Administration (USA)
|
FECS | Federation of European Cancer Societies
|
FEV | Forced expectorant volume (a lung test)
|
FFA | For Further Appointment
|
FIGO | Federation Internat. Gyn. Obst. (FIGO Gynaecological staging system)
|
FISH | Flourescence in situ Hybridisation
|
FMTC | Familial Medullary Thyroid Carcinoma
|
FNA | Fine Needle Aspiration - a type of biposy using a thin needle (or FNAB)
|
FU | Follow up
|
FVC | Forced Vital Capacity
|
g | gram - unit of weight
|
G-CSF | Granulocyte colony stimulating factor promotes production of white blood cells
|
GA | General Anaesthetic
|
GCP | Good Clinical Practice (guidelines)
|
GCT | Germ Cell Tumour
|
GCT | Giant Cell Tumour Context: bone tumours
|
GFR | Gromerular filtration rate
|
GI | Gastrointestinal
|
GM-CSF | Granulocyte and macrophage colony stimulating factor
|
GMC | General Medical Council (UK)
|
GPOH | Gesellschaft fur Padiatrische Onkologie und Hamatologie (German Paed. Onc Group)
|
GPR | Good Partial Remission
|
GU | Genito-urinary
|
GvHD | Graft versus Host Disease
|
Gy | Grays (units of radiation)
|
H&E | Hematoxylin and Eosin (stain)
|
H/O | History of
|
Hb | Haemoglobin
|
HCC | Hepatocellular Carcinoma
|
HCG | Human Chorionic Gonadotrophin (hormone)
|
HCL | Hairy Cell Leukaemia
|
HCO3 | Bicarbonate
|
HD | Hodgkin's Disease (lymphoma)
|
HD | High dose
|
HDC | High Dose Chemotherapy
|
HIV | Human Immunodeficiency Virus
|
HL-A | Human Leukocyte Associated antigens (HL-A matching for BMT)
|
HNPCC | Hereditary NonPolyposis Colorectal Cancer
|
HPV | Human Papilloma Virus - implicated in some gynacological cancers
|
HR | High risk
|
HRT | Hormone replacement therapy
|
HTLV | Human T-cell leukemia-lymphoma virus
|
I-131 | Radioactive Iodine
|
IACR | International Association of Cancer Registries
|
IARC | International Agency for Research on Cancer
|
IASLC | International Association for the Study of Lung Cancer
|
ICARE | International Cancer Alliance for Research and Education (ICARE)
|
ICCCPO | International Confederation of Childhood Cancer Parent Organisations
|
ICCG | International Collaborative Cancer Group
|
ICCPO | Icelandic Childhood Cancer Parent Organisation
|
ICD | International Classification of Diseases (coding system)
|
ICDO | International Classification of Diseases for Oncology (coding system)
|
ICF | Intercellular fluid
|
ICH | International Conference on Harmonization (GCP)
|
ICRF | Imperial Cancer Research Fund (UK)
|
ICU | Intensive Care Unit
|
IESS | Intergroup Ewing's Sarcoma Study (USA)
|
IL2 | Interleukin2
|
IM | Intramuscular - into a muscle
|
IMF | International Myeloma Foundation
|
IMRT | Intensity-Modulated Radiotherapy
|
INFA | International Neurofibromatosis Association
|
INSS | International Neuroblastoma Staging System
|
IPSO | International Society of Pediatric Surgical Oncology
|
ITU | Intensive Therapy Unit
|
IU | International units
|
IV | Intravenous - into a vein
|
IVP | Intravenous Pyelogram - type of Xray after injection with iodine dye
|
IWMF | International Waldenstrom's Maroglubulinemia Foundation
|
JCO | Journal of Clinical Oncology
|
K+ | Potassium
|
kg | Kilogram - a thousand grams
|
l | liter - unit of volume
|
L1 - L5 | Lumbar vertebrae 1 - 5 (spine eg. L1 = 1st lumbar vertebra)
|
LCH | Langerhans cell histiocytocis
|
LCIS | Lobular Carcinoma In Situ - type of breast cancer
|
LDH | Lactic dehydrogenase -high levels correlate with tumour volume in some cancers
|
LMM | Lentigo Maligna Melanoma
|
LMP | Low Malignant Potential (context: ovarian tumours)
|
LN | Lymph Node
|
LP | Lumbar puncture
|
LREC | Local Research Ethics Committee (UK)
|
LRF | Leukaemia Research Fund (UK)
|
LRFA | Lymphoma Research Foundation of America
|
LVEF | Left Ventricular Fjection Fraction - a heart function test
|
LVSF | Left Ventricular Shortening Fraction - a heart function test
|
Lx | Lumpectomy
|
m | meter (unit of length)
|
M/H | Medical history
|
MAB - mAb | Monoclonal antibody
|
MCA | Medicines Control Agency (UK)
|
MDR | Multi drug resistant
|
MDS | Myelo dysplastic syndrome
|
MEN | Multiple Endocrine Neoplasia - (familial) a.k.a. FMEN
|
mEq/l | milliequivalent per liter
|
mets | Metastases (where the tumour has spread to secondary sites)
|
Mg | Magnesium
|
mg | milligram - 0.001 gram
|
MI | Miocardial Infarction
|
mIBG | Radioactive Iodine Metaidobenzoguanidine (mIBG scans or mIBG therapy).
|
ml | millilitre 0.001 liter
|
MM | Malignant Melanoma
|
mM | millimole
|
mm | millimeter - 0.001 meters
|
MM | Multiple Myeloma
|
mOsm | milliosmole
|
MPNST | Malignant Peripheral Nerve Sheath Tumour
|
MPO | Medical and Pediatric Oncology (journal)
|
MRC | Medical Research Council (UK)
|
MREC | Multi-centre Research Ethics Committee (UK)
|
MRI | Magnetic resonance imaging (scan)
|
MRT | Malignant Rhabdoid Tumour
|
MSSU | Mid stream specimen urine
|
MTD | Maximum tolerated dose - phase 1 studies
|
MTX | Methotrexate (anti cancer drug)
|
MUD | Matched Urelated Donor - for bone marrow transplant
|
Mx | Mastectomy
|
N/V | Nausea and vomiting
|
Na+ | Sodium
|
NAACCR | North American Association of Central Cancer Registries
|
NABCO | National Alliance of Breast Cancer Organizations
|
NAD | No Abnormality Detected
|
NBCCS | Nevoid basal cell carcinoma syndrome
|
NBM | Nil by mouth
|
NCCF | National Childhood Cancer Foundation (USA)
|
NCI | National Cancer Institue (USA)
|
NCIC | National Cancer Institute of Canada
|
NCRA | National Cancer Registrars Association (USA)
|
NECCR | North of England Children's Cancer Research Unit
|
NED | No evidence of disease
|
ng | nanogram - 0.000000001 gram
|
NHL | Non Hodgkin's Lymphoma
|
NK | Natural Killer cells (large lymphocytes, part of the immune system)
|
NK | Not known
|
NKCA | National Kidney Cancer Association (USA)
|
NM | Nodular Melanoma
|
NMR | Nuclear magnetic resonance (scan)
|
NMSC | Non Melanoma Skin Cancer
|
NNFF | National Neurofibromatosis Foundation (USA)
|
NORD | National Organization for Rare Disorders (USA)
|
NOS | Not otherwise specified (see ICDO)
|
NPC | Nasopharyngeal Carcinoma
|
NRCT | National Registry of Childhood Tumours (UK) held by the CCRG at Oxford
|
NRSTS | Non-Rhabdomyosarcoma Soft Tissue Sarcoma
|
NSCLC | Non-small cell lung cancer
|
NSE | Neuron-Specific Enolase - a neural marker
|
NSR | Non significant result
|
NSR | Normal Sinus Rhythem
|
O/E | On Examination
|
OECI | Organization of European Cancer Institutes
|
ONB | Olfactory Neuroblastoma
|
OS | Overall Survival
|
OS | Osteogenic sarcoma (context bone tumours)
|
PBSC | Peripheral Blood Stem Cell (see PBSCT)
|
PBSCH | Peripheral Blood Stem Cell Harvest
|
PBSCR | Peripheral Blood Stem Cell Rescue (transplant)
|
PBSCT | Peripheral Blood Stem Cell Transplant
|
PD | Progressive disease
|
PDQ | Physician's Data Query (CancerNet)
|
PET | Positron Emmission Tomography- a scan after a small radioactive injection.
|
PET | Pancreatic Endocrine Tumor
|
PFS | Progression Free Survival
|
pg | picogram - 0.000000000001 gram
|
pH | hydrogen-ion concentration - acid / alkaline
|
PH | Past History
|
PLB | Primary Lymphoma of Bone
|
PNET | Primitive neuroectodermal tumour Context: CNS tumours
|
PNET | Peripheral neuroectodermal tumour Context: Bone tumours - see Ewing's tu
|
PNS | Peripheral nervous system - nervous system outside the brain and spine.
|
POG | Pediatric Oncology Group (USA)
|
PONF | Paediatric Oncology Nurses Forum (UK)
|
PR | Partial Responce / Partial Remission
|
PR | per rectum
|
prn | as required
|
prn | whenever necessary (pro re nata)
|
PSA | prostate-specific antigen - PSA test used in screening for prostate cancer
|
PUD | Peri-Urethral Diathermy (associated with superficial bladder cancer)
|
QALY | Quality-Adjusted Life Year
|
qid | Four times a day (quater in die)
|
QoL | Quality of Life
|
RBC | Red blood cell / red blood count
|
RCT | Randomised Controlled Trial
|
RFS | Relapse free survival - Time from diagnosis to relapse or death.
|
RIGS | Radioimmunoguided surgery
|
RMS | Rhabdomyosarcoma
|
RNA | ribonucleic acid
|
RT | Radiotherapy
|
RTPCR | Reverse transcriptase polymerase chain reaction
|
Rx | Treatment
|
SA | Surface area (see BSA)
|
SAE | Serious Adverse Event
|
SC | Subcutaneous
|
SCC | Squamous Cell Carcinoma
|
SCLC | Small cell lung cancer
|
SCTN | Scottish Cancer Therapy Network
|
SD | Stable Disease
|
SDV | Source Data Verification
|
SEER | Surveillance, Epidemiology, and End Results (USA)
|
SFOP | French Paediatric Oncology Scociety
|
SGDM | Study Group on Data Management (EORTC)
|
SGO | Society of Gynecologic Oncologists
|
SGOT | Serum glutamic oxalacetic transaminase - a liver function test
|
SGPT | Serum glutamic pyruvic transaminase - a liver function test
|
SH | Social history
|
SHO | Senior House Officer
|
SIADH | Syndrome of Inappropriate Antidiuretic Hormone
|
SIOP | International Society of Paediatric Oncology
|
SNLG | Scottish and Newcastle Lymphoma Group
|
SNP | Single Nucleotide Polymorphism
|
SOB | Short of breath
|
SPOHNC | Support for People with Oral and Head and Neck Cancer
|
SSM | Superficial Spreading Melanoma
|
SWOG | Southwest Oncology Group (USA)
|
T1 - T12 | Thoracic vertebrae 1-12 (spine eg. T10 = tenth thoracic vertibra)
|
TBI | Total body irradiation
|
TCC | Transitional Cell Carcinoma (usually bladder cancer)
|
TCP | Thrombocytopenia
|
tds / tid | Three times a day (ter in die)
|
TNF | Tumour Necrosis Factor
|
TNM | Staging system - primary tumour
|
TPN | total parenteral nutrition
|
TRK | Transketolase
|
U&Es | Urea and Electrolites
|
UA | Urine analysis
|
ug | microgram - 0.000001 gram
|
UICC | Union Internationale Contre le Cancer - International Union Against Cancer
|
UKACR | UK Association of Cancer Registeries
|
UKCCCR | UK Coordinating Committee for Cancer Research
|
UKCCRG | UK Children's Cancer Research Group (Oxford)
|
UKCCSG | UK Children's Cancer Study Group (UK)
|
ULN | Upper Limits of Normal
|
URTI | Upper respiratory tract infection
|
US | Ultasound (scan)
|
UTI | Urinary Tract Infection
|
UVR | Ultra Violet Radiation
|
VEF | Ventricular ejection fraction (tests lung function)
|
VM-26 | Teniposide (anti cancer drug)
|
VMA | Vanillylmandelic Acid
|
VP-16 | Etoposide (anti cancer drug)
|
WBC | White blood cell count
|
WCC | White cell count
|
WHO | World Health Organisation
|
XRT | Radiotherapy (external)
|
YST | Yolk sac tumour - another name for germ cell tumour
|
